Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1994 Aug;72(2 Suppl):S68–S72. doi: 10.1136/hrt.72.2_suppl.s68

Results of clinical trials with diuretics in heart failure

J R Hampton 1
PMCID: PMC1025580  PMID: 7946764

Full text

PDF
S68

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bayliss J., Norell M., Canepa-Anson R., Sutton G., Poole-Wilson P. Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics. Br Heart J. 1987 Jan;57(1):17–22. doi: 10.1136/hrt.57.1.17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Burnier M., Brunner H. R. Neurohormonal consequences of diuretics in different cardiovascular syndromes. Eur Heart J. 1992 Dec;13 (Suppl G):28–33. doi: 10.1093/eurheartj/13.suppl_g.28. [DOI] [PubMed] [Google Scholar]
  3. Cheng T. O. Acronym aggravation. Br Heart J. 1994 Jan;71(1):107–109. doi: 10.1136/hrt.71.1.107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cleland J. G., Dargie H. J., Ford I. Mortality in heart failure: clinical variables of prognostic value. Br Heart J. 1987 Dec;58(6):572–582. doi: 10.1136/hrt.58.6.572. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cleland J. G., Dargie H. J., Hodsman G. P., Ball S. G., Robertson J. I., Morton J. J., East B. W., Robertson I., Murray G. D., Gillen G. Captopril in heart failure. A double blind controlled trial. Br Heart J. 1984 Nov;52(5):530–535. doi: 10.1136/hrt.52.5.530. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cohn J. N., Johnson G., Ziesche S., Cobb F., Francis G., Tristani F., Smith R., Dunkman W. B., Loeb H., Wong M. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 1991 Aug 1;325(5):303–310. doi: 10.1056/NEJM199108013250502. [DOI] [PubMed] [Google Scholar]
  7. Cowley A. J., Rowley J. M., Stainer K. L., Hampton J. R. Captopril therapy for heart failure. A placebo controlled study. Lancet. 1982 Oct 2;2(8301):730–732. doi: 10.1016/s0140-6736(82)90920-5. [DOI] [PubMed] [Google Scholar]
  8. Cowley A. J., Stainer K., Wynne R. D., Rowley J. M., Hampton J. R. Symptomatic assessment of patients with heart failure: double-blind comparison of increasing doses of diuretics and captopril in moderate heart failure. Lancet. 1986 Oct 4;2(8510):770–772. doi: 10.1016/s0140-6736(86)90298-9. [DOI] [PubMed] [Google Scholar]
  9. Dahlöf B., Lindholm L. H., Hansson L., Scherstén B., Ekbom T., Wester P. O. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension) Lancet. 1991 Nov 23;338(8778):1281–1285. doi: 10.1016/0140-6736(91)92589-t. [DOI] [PubMed] [Google Scholar]
  10. Davies R. F., Beanlands D. S., Nadeau C., Phaneuf D., Morris A., Arnold J. M., Parker J. O., Baigrie R., Latour P., Klinke W. P. Enalapril versus digoxin in patients with congestive heart failure: a multicenter study. Canadian Enalapril Versus Digoxin Study Group. J Am Coll Cardiol. 1991 Dec;18(7):1602–1609. doi: 10.1016/0735-1097(91)90491-q. [DOI] [PubMed] [Google Scholar]
  11. DiBianco R., Shabetai R., Kostuk W., Moran J., Schlant R. C., Wright R. A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure. N Engl J Med. 1989 Mar 16;320(11):677–683. doi: 10.1056/NEJM198903163201101. [DOI] [PubMed] [Google Scholar]
  12. Hampton J. R. Comparative efficacy of diuretics: benefit versus risk: results of clinical trials. Eur Heart J. 1992 Dec;13 (Suppl G):85–91. doi: 10.1093/eurheartj/13.suppl_g.85. [DOI] [PubMed] [Google Scholar]
  13. Ikram H., Chan W., Espiner E. A., Nicholls M. G. Haemodynamic and hormone responses to acute and chronic frusemide therapy in congestive heart failure. Clin Sci (Lond) 1980 Dec;59(6):443–449. doi: 10.1042/cs0590443. [DOI] [PubMed] [Google Scholar]
  14. Kannel W. B. Epidemiology and prevention of cardiac failure: Framingham Study insights. Eur Heart J. 1987 Sep;8 (Suppl F):23–26. doi: 10.1093/eurheartj/8.suppl_f.23. [DOI] [PubMed] [Google Scholar]
  15. Kiyingi A., Field M. J., Pawsey C. C., Yiannikas J., Lawrence J. R., Arter W. J. Metolazone in treatment of severe refractory congestive cardiac failure. Lancet. 1990 Jan 6;335(8680):29–31. doi: 10.1016/0140-6736(90)90148-x. [DOI] [PubMed] [Google Scholar]
  16. Kleber F. X., Niemöller L., Doering W. Impact of converting enzyme inhibition on progression of chronic heart failure: results of the Munich Mild Heart Failure Trial. Br Heart J. 1992 Apr;67(4):289–296. doi: 10.1136/hrt.67.4.289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Kramer B. L., Massie B. M., Topic N. Controlled trial of captopril in chronic heart failure: a rest and exercise hemodynamic study. Circulation. 1983 Apr;67(4):807–816. doi: 10.1161/01.cir.67.4.807. [DOI] [PubMed] [Google Scholar]
  18. Larsen F. F. Haemodynamic effects of high or low doses of furosemide in acute myocardial infarction. Eur Heart J. 1988 Feb;9(2):125–131. doi: 10.1093/oxfordjournals.eurheartj.a062465. [DOI] [PubMed] [Google Scholar]
  19. Massie B. M. Effect of diuretic therapy on hypertensive left ventricular hypertrophy. Eur Heart J. 1992 Dec;13 (Suppl G):53–60. doi: 10.1093/eurheartj/13.suppl_g.53. [DOI] [PubMed] [Google Scholar]
  20. Moser M. Diuretics and cardiovascular risk factors. Eur Heart J. 1992 Dec;13 (Suppl G):72–80. doi: 10.1093/eurheartj/13.suppl_g.72. [DOI] [PubMed] [Google Scholar]
  21. Odemuyiwa O., Gilmartin J., Kenny D., Hall R. J. Captopril and the diuretic requirements in moderate and severe chronic heart failure. Eur Heart J. 1989 Jul;10(7):586–590. doi: 10.1093/oxfordjournals.eurheartj.a059535. [DOI] [PubMed] [Google Scholar]
  22. Packer M., Carver J. R., Rodeheffer R. J., Ivanhoe R. J., DiBianco R., Zeldis S. M., Hendrix G. H., Bommer W. J., Elkayam U., Kukin M. L. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med. 1991 Nov 21;325(21):1468–1475. doi: 10.1056/NEJM199111213252103. [DOI] [PubMed] [Google Scholar]
  23. Packer M. Pathophysiology of chronic heart failure. Lancet. 1992 Jul 11;340(8811):88–92. doi: 10.1016/0140-6736(92)90405-r. [DOI] [PubMed] [Google Scholar]
  24. Remes J., Tikkanen I., Fyhrquist F., Pyörälä K. Neuroendocrine activity in untreated heart failure. Br Heart J. 1991 May;65(5):249–255. doi: 10.1136/hrt.65.5.249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Richardson A., Bayliss J., Scriven A. J., Parameshwar J., Poole-Wilson P. A., Sutton G. C. Double-blind comparison of captopril alone against frusemide plus amiloride in mild heart failure. Lancet. 1987 Sep 26;2(8561):709–711. doi: 10.1016/s0140-6736(87)91074-9. [DOI] [PubMed] [Google Scholar]
  26. Sharpe N., Murphy J., Smith H., Hannan S. Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction. Lancet. 1988 Feb 6;1(8580):255–259. doi: 10.1016/s0140-6736(88)90347-9. [DOI] [PubMed] [Google Scholar]
  27. Stampfer M., Epstein S. E., Beiser G. D., Braunwald E. Hemodynamic effects of diuresis at rest and during intense upright exercise in patients with impaired cardiac function. Circulation. 1968 Jun;37(6):900–911. doi: 10.1161/01.cir.37.6.900. [DOI] [PubMed] [Google Scholar]
  28. Wilson J. R., Reichek N., Dunkman W. B., Goldberg S. Effect of diuresis on the performance of the failing left ventricle in man. Am J Med. 1981 Feb;70(2):234–239. doi: 10.1016/0002-9343(81)90755-5. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES